TP53 and prostate carcinoma: Among the most enriched pathways in which the targets of these 14 miRNAs were “MicroRNAs in cancer”, “Prostate cancer” and various signaling pathways frequently altered in cancer, such as the PI3K–Akt signaling pathway, p53 signaling pathway, and FoxO signaling pathway (Figure 5b).